[Predictive factors for MASLD in type 2 diabetes: 1 year follow-up study]. [PDF]
H Wacher N +8 more
europepmc +1 more source
[Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control]. [PDF]
Roca-Rodríguez MM +6 more
europepmc +1 more source
[Leuko-glycemic index as a marker of inflammation and endothelial dysfunction in overweight and obesity]. [PDF]
Villalpando-Sánchez DC +1 more
europepmc +1 more source
[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician]. [PDF]
Sáenz-San Martín A +3 more
europepmc +1 more source
El papel del IMC, las moléculas del perfil lipídico sérico y sus índices derivados en los pólipos colorrectales. [PDF]
Huang C, Liang W, Sun Y.
europepmc +1 more source
[Consensus document for the detection and management of chronic kidney disease]. [PDF]
Martínez-Castelao A +20 more
europepmc +1 more source
[Diabetic autonomic neuropathy diagnosed in primary care in patients with type 2 diabetes]. [PDF]
Collado Márquez S +5 more
europepmc +1 more source
[Randomised controlled trial: the role of diet and exercise in women with metabolic syndrome]. [PDF]
Miguel Soca PE +5 more
europepmc +1 more source

